{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:06:20Z","timestamp":1784387180780,"version":"3.55.0"},"reference-count":80,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2015,11]]},"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is a heterogeneous disorder of reproduction and metabolism, which emerges at puberty, and is characterised by a wide spectrum of signs and symptoms of hyperandrogenism, anovulation, hyperinsulinaemia and associated comorbidities. Unlike adult PCOS, there are no agreed-upon diagnostic criteria for adolescent PCOS, but hyperandrogenaemia remains the sine qua non for its diagnosis. Many adolescent girls with PCOS are overweight\/obese, and have a heightened risk for comorbidities such as dysglycaemia, dyslipidaemia, fatty liver disease, sleep apnoea and cardiovascular disease. Therefore, early and accurate diagnosis is essential for implementation of appropriate treatment and management. Available treatments include lifestyle modifications, hormonal contraceptives and insulin sensitisers. However, there are limited data on the best treatment modalities in adolescents. The objective of this review is to describe the clinical manifestations of PCOS in adolescents and the appropriate diagnostic work-up. The optimal treatment modalities based on a review of the available adult and adolescent literature will be discussed.<\/jats:p>","DOI":"10.1136\/archdischild-2014-306471","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T01:35:18Z","timestamp":1435023318000},"page":"1076-1083","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Optimal management of polycystic ovary syndrome in adolescence"],"prefix":"10.1136","volume":"100","author":[{"given":"Natalie","family":"Hecht Baldauff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silva","family":"Arslanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,6,22]]},"reference":[{"key":"key-10.1136\/archdischild-2014-306471-1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-2","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/humrep\/des113","article-title":"Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study","volume":"27","author":"Cinar","year":"2012","journal-title":"Hum Reprod"},{"key":"key-10.1136\/archdischild-2014-306471-3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.1136\/archdischild-2014-306471-4","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","volume-title":"Polycystic ovary syndrome","author":"Zawadzki","year":"1992"},{"key":"key-10.1136\/archdischild-2014-306471-5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","journal-title":"Hum Reprod"},{"key":"key-10.1136\/archdischild-2014-306471-6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"key-10.1136\/archdischild-2014-306471-7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"key-10.1136\/archdischild-2014-306471-8","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1471-0528.2009.02421.x","article-title":"Reproductive endocrinology of adolescent polycystic ovary syndrome","volume":"117","author":"Shayya","year":"2010","journal-title":"BJOG"},{"key":"key-10.1136\/archdischild-2014-306471-10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1043-2760(98)00020-4","article-title":"Endocrine and metabolic abnormalities in adolescents with a PCOS-like condition: consequences for adult reproduction","volume":"9","author":"Apter","year":"1998","journal-title":"Trends Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-11","first-page":"1021","article-title":"Rapid maturation of the reproductive axis during perimenarche independent of body composition","volume":"85","author":"Legro","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/humrep\/deh079","article-title":"Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years","volume":"19","author":"van Hooff","year":"2004","journal-title":"Hum Reprod"},{"key":"key-10.1136\/archdischild-2014-306471-13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1203\/01.pdr.0000246097.73031.27","article-title":"Longitudinal study of physiologic insulin resistance and metabolic changes of puberty","volume":"60","author":"Hannon","year":"2006","journal-title":"Pediatr Res"},{"key":"key-10.1136\/archdischild-2014-306471-15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","article-title":"A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome","volume":"72","author":"Nestler","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/jc.2006-2002","article-title":"Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls","volume":"92","author":"McCartney","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-17","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1210\/jc.2005-0438","article-title":"Androgens before and after weight loss in obese children","volume":"90","author":"Reinehr","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0015-0282(16)56160-3","article-title":"Standards for ovarian volume in childhood and puberty","volume":"60","author":"Bridges","year":"1993","journal-title":"Fertil Steril"},{"key":"key-10.1136\/archdischild-2014-306471-19","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1210\/jc.2006-0835","article-title":"Functional significance of polycystic-size ovaries in healthy adolescents","volume":"91","author":"Mortensen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-20","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/humrep\/der102","article-title":"Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis","volume":"26","author":"Hickey","year":"2011","journal-title":"Hum Reprod"},{"key":"key-10.1136\/archdischild-2014-306471-21","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","article-title":"Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients","volume":"10","author":"Balen","year":"1995","journal-title":"Hum Reprod"},{"key":"key-10.1136\/archdischild-2014-306471-22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0889-8545(00)80008-X","article-title":"Disorders of excessive hair growth in the adolescent","volume":"27","author":"Plouffe","year":"2000","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"(Suppl 5)","key":"key-10.1136\/archdischild-2014-306471-24","first-page":"1285","article-title":"Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism","volume":"13","author":"Rosenfield","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpag.2009.04.004","article-title":"Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome","volume":"23","author":"Bekx","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"key-10.1136\/archdischild-2014-306471-26","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1210\/jc.2005-1852","article-title":"The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism","volume":"91","author":"McCartney","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1515\/JPEM.2007.20.1.41","article-title":"Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovary syndrome","volume":"20","author":"Littlejohn","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-28","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.fertnstert.2013.04.001","article-title":"Prevalence of polycystic ovary syndrome in adolescents","volume":"100","author":"Christensen","year":"2013","journal-title":"Fertil Steril"},{"key":"key-10.1136\/archdischild-2014-306471-29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1196\/annals.1429.024","article-title":"Menstrual health and the metabolic syndrome in adolescents","volume":"1135","author":"Tfayli","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.1136\/archdischild-2014-306471-30","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1210\/jc.2002-021499","article-title":"Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome","volume":"88","author":"Yildiz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-31","doi-asserted-by":"crossref","first-page":"E1519","DOI":"10.1073\/pnas.1400574111","article-title":"Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype","volume":"111","author":"McAllister","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"key-10.1136\/archdischild-2014-306471-32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.beem.2006.02.002","article-title":"Treatment of PCOS in adolescence","volume":"20","author":"Warren-Ulanch","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bpobgyn.2009.09.005","article-title":"PCOS in adolescents","volume":"24","author":"Diamanti-Kandarakis","year":"2010","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"key-10.1136\/archdischild-2014-306471-34","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jpeds.2010.11.026","article-title":"Diagnosis of diabetes using hemoglobin A1c: should recommendations in adults be extrapolated to adolescents?","volume":"158","author":"Lee","year":"2011","journal-title":"J Pediatr"},{"key":"key-10.1136\/archdischild-2014-306471-35","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.2337\/dc10-1984","article-title":"Utility of hemoglobin A(1c) for diagnosing prediabetes and diabetes in obese children and adolescents","volume":"34","author":"Nowicka","year":"2011","journal-title":"Diabetes Care"},{"key":"key-10.1136\/archdischild-2014-306471-36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0889-8545(05)70188-1","article-title":"Diabetes prevalence and risk factors in polycystic ovary syndrome","volume":"28","author":"Legro","year":"2001","journal-title":"Obstet Gynecol Clin North Am"},{"key":"key-10.1136\/archdischild-2014-306471-37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"key-10.1136\/archdischild-2014-306471-38","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1210\/jcem.87.3.8305","article-title":"Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome","volume":"87","author":"Palmert","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"issue":"2","key":"key-10.1136\/archdischild-2014-306471-40","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.1136\/archdischild-2014-306471-41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.beem.2006.03.008","article-title":"Role of lifestyle modification in the management of polycystic ovary syndrome","volume":"20","author":"Hoeger","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-42","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","article-title":"The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials","volume":"93","author":"Hoeger","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpag.2011.01.002","article-title":"Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome","volume":"24","author":"Ornstein","year":"2011","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"key-10.1136\/archdischild-2014-306471-44","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1210\/jc.2011-1609","article-title":"Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls","volume":"96","author":"Lass","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jpag.2012.06.008","article-title":"Factors contributing to initial weight loss among adolescents with polycystic ovary syndrome","volume":"25","author":"Geier","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"key-10.1136\/archdischild-2014-306471-46","doi-asserted-by":"crossref","first-page":"298067","DOI":"10.1155\/2012\/298067","article-title":"Parents\u2019 readiness to change affects BMI reduction outcomes in adolescents with polycystic ovary syndrome","volume":"2012","author":"Jakubowski","year":"2012","journal-title":"J Obes"},{"key":"key-10.1136\/archdischild-2014-306471-47","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/jpepsy\/jsn057","article-title":"Cognitive-behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study","volume":"34","author":"Rofey","year":"2009","journal-title":"J Pediatr Psychol"},{"issue":"(5 Pt 1)","key":"key-10.1136\/archdischild-2014-306471-48","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0029-7844(02)02725-4","article-title":"The evaluation and management of hirsutism","volume":"101","author":"Azziz","year":"2003","journal-title":"Obstet Gynecol"},{"key":"key-10.1136\/archdischild-2014-306471-49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0010-7824(99)00025-6","article-title":"Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives","volume":"59","author":"van Heusden","year":"1999","journal-title":"Contraception"},{"key":"key-10.1136\/archdischild-2014-306471-50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/13625180600983082","article-title":"Efficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndrome","volume":"12","author":"Pehlivanov","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"key-10.1136\/archdischild-2014-306471-51","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","article-title":"Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives","volume":"77","author":"Mastorakos","year":"2002","journal-title":"Fertil Steril"},{"key":"key-10.1136\/archdischild-2014-306471-52","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2005.07.1306","article-title":"Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome","volume":"85","author":"Mastorakos","year":"2006","journal-title":"Fertil Steril"},{"key":"key-10.1136\/archdischild-2014-306471-53","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2010-2547","article-title":"Drospirenone\/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors","volume":"96","author":"Tfayli","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-54","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/humupd\/dmt028","article-title":"Venous thromboembolism in women: a specific reproductive health risk","volume":"19","author":"ESHRE Capri Workshop Group","year":"2013","journal-title":"Hum Reprod Update"},{"key":"key-10.1136\/archdischild-2014-306471-55","first-page":"3526","article-title":"Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche","volume":"85","author":"Ibanez","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpedi.160.3.241","article-title":"Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome","volume":"160","author":"Bridger","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"key-10.1136\/archdischild-2014-306471-57","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1515\/JPEM.2006.19.6.831","article-title":"Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome","volume":"19","author":"Glueck","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-58","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/humrep\/del185","article-title":"Metformin treatment is effective in obese teenage girls with PCOS","volume":"21","author":"De Leo","year":"2006","journal-title":"Hum Reprod"},{"key":"key-10.1136\/archdischild-2014-306471-59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1067\/mpd.2001.109603","article-title":"Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome","volume":"138","author":"Lewy","year":"2001","journal-title":"J Pediatr"},{"key":"key-10.1136\/archdischild-2014-306471-60","first-page":"66","article-title":"Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease","volume":"86","author":"Arslanian","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-61","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jcem.87.4.8398","article-title":"Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance","volume":"87","author":"Arslanian","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-62","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/j.fertnstert.2011.05.048","article-title":"Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study","volume":"95","author":"Ladson","year":"2011","journal-title":"Fertil Steril"},{"key":"key-10.1136\/archdischild-2014-306471-63","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1210\/jc.2004-0463","article-title":"Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment","volume":"89","author":"Ibanez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpeds.2003.08.015","article-title":"Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome","volume":"144","author":"Ibanez","year":"2004","journal-title":"J Pediatr"},{"key":"key-10.1136\/archdischild-2014-306471-65","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.2004-1376","article-title":"Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance","volume":"90","author":"Sepilian","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-66","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2004-1965","article-title":"Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome","volume":"90","author":"Ortega-Gonzalez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-67","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/eje.1.01948","article-title":"Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome","volume":"153","author":"Tarkun","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"key-10.1136\/archdischild-2014-306471-68","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2003-031780","article-title":"Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study","volume":"89","author":"Ganie","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-69","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03345529","article-title":"Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile","volume":"28","author":"Zulian","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"key-10.1136\/archdischild-2014-306471-70","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1210\/jc.2013-1040","article-title":"Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study","volume":"98","author":"Ganie","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-71","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2007-2437","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline","volume":"93","author":"Martin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-72","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-73","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.1136\/archdischild-2014-306471-74","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00404-014-3217-5","article-title":"Comparison of two oral contraceptive forms containing cyproterone acetate and drospirenone in the treatment of patients with polycystic ovary syndrome: a randomized clinical trial","volume":"290","author":"Kahraman","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"key-10.1136\/archdischild-2014-306471-75","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1210\/jc.2007-2430","article-title":"Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials","volume":"93","author":"Swiglo","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2014-306471-76","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpag.2013.09.010","article-title":"Intermittent low-dose finasteride administration is effective for treatment of hirsutism in adolescent girls: a pilot study","volume":"27","author":"Tartagni","year":"2014","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"key-10.1136\/archdischild-2014-306471-77","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2005.01327.x","article-title":"Evidence-based review of hair removal using lasers and light sources","volume":"20","author":"Haedersdal","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.1136\/archdischild-2014-306471-78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1524-4725.2000.99104.x","article-title":"Comparison of alexandrite laser and electrolysis for hair removal","volume":"26","author":"Gorgu","year":"2000","journal-title":"Dermatol Surg"},{"key":"key-10.1136\/archdischild-2014-306471-79","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/8.2.169","article-title":"Laser hair reduction in the hirsute patient: a critical assessment","volume":"8","author":"Sanchez","year":"2002","journal-title":"Hum Reprod Update"},{"key":"key-10.1136\/archdischild-2014-306471-80","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-4632.2006.03079.x","article-title":"Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair","volume":"46","author":"Wolf","year":"2007","journal-title":"Int J Dermatol"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2014-306471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T10:41:08Z","timestamp":1601116868000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2014-306471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,22]]},"references-count":80,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,10,19]]},"published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1136\/archdischild-2014-306471"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2014-306471","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,22]]}}}